Carlsson K H, Jurna I
Institut für Pharmakologie der Universität des Saarlandes, Homburg, F.R.G.
Eur J Pharmacol. 1987 Jul 2;139(1):1-10. doi: 10.1016/0014-2999(87)90491-2.
The analgesic agent, tramadol, was tested on motor and sensory responses of the nociceptive system in rats. The tail-flick response to radiant heat was dose dependently depressed by tramadol (1-10 mg/kg i.p.), and the antinociceptive effect of the drug was reduced by naloxone in the same range of doses that antagonized the effect of morphine. Tramadol (100 micrograms) microinjected into the periaqueductal grey (PAG) prolonged the tail-flick latency and this effect was abolished by naloxone (0.2 mg/kg i.p.). Aminophylline (25 mg/kg i.p.) did not prevent the antinociceptive effect of tramadol (5 mg/kg i.p.). Tramadol (20 and 40 mg/kg injected i.v.; 100 and 200 micrograms injected intrathecally (i.t.); 100 micrograms injected into the PAG) depressed both the spontaneous activity in ascending axons and their activity due to stimulation of afferent C fibres and co-activation from afferent A delta fibres in the sural nerve. Naloxone injected i.v. at a dose (0.2 mg/kg) that had proven fully effective against the effects of morphine antagonized only the effect on spontaneous activity caused by i.v. injection of tramadol. A high dose of naloxone (1 mg/kg i.v.) not only abolished the depression of spontaneous activity caused by an i.t. injection of tramadol (200 micrograms) but also significantly reduced (but did not abolish) the activity in ascending axons evoked from afferent C fibres while the depression of co-activation from afferent A delta fibres remained unchanged. Aminophylline (50 micrograms i.t.) failed to abolish the depression by tramadol of ascending nociceptive activity. The activity elicited in ascending axons by stimulation of afferent A beta fibres was not changed by i.t. injection of tramadol (200 micrograms), which was evidence that the antinociceptive effect of tramadol is not due to a local anaesthetic action. It is concluded that tramadol produces its antinociceptive and analgesic effects through spinal and supraspinal sites of action. Since the effects of tramadol and morphine differ in some respects, it must be assumed that they are due to binding to different opiate receptors or that some of the effects of tramadol are not mediated by opiate receptors alone.
对镇痛药曲马多进行了大鼠伤害性感受系统运动和感觉反应的测试。曲马多(腹腔注射1 - 10毫克/千克)对辐射热引起的甩尾反应呈剂量依赖性抑制,且在拮抗吗啡作用的相同剂量范围内,纳洛酮可降低该药物的镇痛作用。向导水管周围灰质(PAG)微量注射曲马多(100微克)可延长甩尾潜伏期,且该作用可被纳洛酮(腹腔注射0.2毫克/千克)消除。氨茶碱(腹腔注射25毫克/千克)不能阻止曲马多(腹腔注射5毫克/千克)的镇痛作用。曲马多(静脉注射20和40毫克/千克;鞘内注射100和200微克;注射到PAG 100微克)可抑制腓肠神经中上行轴突的自发活动及其因传入C纤维刺激和传入Aδ纤维共同激活而产生的活动。静脉注射剂量为(0.2毫克/千克)且已证明对吗啡作用完全有效的纳洛酮仅拮抗静脉注射曲马多对自发活动的影响。高剂量纳洛酮(静脉注射1毫克/千克)不仅消除了鞘内注射曲马多(200微克)引起的自发活动抑制,还显著降低(但未消除)传入C纤维诱发的上行轴突活动,而传入Aδ纤维共同激活的抑制作用保持不变。氨茶碱(鞘内注射50微克)未能消除曲马多对上行伤害性活动的抑制。鞘内注射曲马多(200微克)未改变传入Aβ纤维刺激引起的上行轴突活动,这证明曲马多的镇痛作用并非由于局部麻醉作用。得出的结论是,曲马多通过脊髓和脊髓上作用部位产生其镇痛和止痛效果。由于曲马多和吗啡的作用在某些方面有所不同,因此必须假定它们是由于与不同的阿片受体结合,或者曲马多的某些作用并非仅由阿片受体介导。